Nursing Intervention and Summary of Evidence Pertaining to Neonatal Recurrent Hypoglycemia Induced by Terbutaline.
hypoglycemia
neonatal recurrent hypoglycemia
neonate
terbutaline
Journal
Diabetes, metabolic syndrome and obesity : targets and therapy
ISSN: 1178-7007
Titre abrégé: Diabetes Metab Syndr Obes
Pays: New Zealand
ID NLM: 101515585
Informations de publication
Date de publication:
2023
2023
Historique:
received:
07
06
2023
accepted:
10
08
2023
medline:
11
9
2023
pubmed:
11
9
2023
entrez:
11
9
2023
Statut:
epublish
Résumé
Neonatal hypoglycemia (NH) is a common clinical symptom that can occur in both normal and critically ill neonates. The placenta is the site of material exchange between the mother and the fetus, a special organ shared by the mother and the fetus during pregnancy, and one of its important functions is to transfer nutrients from the mother to the fetus. Terbutaline is used to relax frequent uterine contractions before delivery, and it can penetrate the placental barrier and affect the normal decomposition of neonatal glycogen. The situation is neonatal hypoglycemia if not timely detection and interventions in time, the neonate may have recurrent hypoglycemia, leading to irreversible nervous system damage, such as neonatal hypoglycemic encephalopathy, and visual and cognitive impairment. The male neonate was a single fetus, with a birth weight of 3660 g and a length of 50 cm. The blood glucose at birth was 5 mmol/L, Apgar score was 9-10, and body temperature was normal. The mother was healthy, was not diabetic, and had no other risk factors for neonatal hypoglycemia. She was injected with 0.25 mg of terbutaline 6 hours before delivery due to frequent uterine contractions. However, it was found that recurrent hypoglycemia occurred in the neonate even after adequate oral feeding. We included evidence-based use of terbutaline 48 hours before delivery as a high-risk factor for hypoglycemia in the rooming-in neonatal hypoglycemia care program, and formulate the corresponding nursing process, with good effect.
Sections du résumé
Background
UNASSIGNED
Neonatal hypoglycemia (NH) is a common clinical symptom that can occur in both normal and critically ill neonates. The placenta is the site of material exchange between the mother and the fetus, a special organ shared by the mother and the fetus during pregnancy, and one of its important functions is to transfer nutrients from the mother to the fetus. Terbutaline is used to relax frequent uterine contractions before delivery, and it can penetrate the placental barrier and affect the normal decomposition of neonatal glycogen. The situation is neonatal hypoglycemia if not timely detection and interventions in time, the neonate may have recurrent hypoglycemia, leading to irreversible nervous system damage, such as neonatal hypoglycemic encephalopathy, and visual and cognitive impairment.
Case Report
UNASSIGNED
The male neonate was a single fetus, with a birth weight of 3660 g and a length of 50 cm. The blood glucose at birth was 5 mmol/L, Apgar score was 9-10, and body temperature was normal. The mother was healthy, was not diabetic, and had no other risk factors for neonatal hypoglycemia. She was injected with 0.25 mg of terbutaline 6 hours before delivery due to frequent uterine contractions. However, it was found that recurrent hypoglycemia occurred in the neonate even after adequate oral feeding.
Conclusion
UNASSIGNED
We included evidence-based use of terbutaline 48 hours before delivery as a high-risk factor for hypoglycemia in the rooming-in neonatal hypoglycemia care program, and formulate the corresponding nursing process, with good effect.
Identifiants
pubmed: 37693327
doi: 10.2147/DMSO.S422456
pii: 422456
pmc: PMC10487710
doi:
Types de publication
Case Reports
Langues
eng
Pagination
2677-2685Informations de copyright
© 2023 Wang et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Pediatrics. 2011 Mar;127(3):575-9
pubmed: 21357346
Am J Obstet Gynecol. 1981 Mar 15;139(6):697-701
pubmed: 7011036
Pediatrics. 2016 Sep;138(3):
pubmed: 27577580
Bull World Health Organ. 1997;75(3):261-90
pubmed: 9277014
An Pediatr (Engl Ed). 2022 Apr;96(4):286-293
pubmed: 35440425
Pediatrics. 2020 Apr;145(4):
pubmed: 32161111
J Pediatr. 1979 Mar;94(3):449-53
pubmed: 423035
Breastfeed Med. 2014 May;9(4):173-9
pubmed: 24823918
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Jan 15;24(1):1-13
pubmed: 35177170
Acta Obstet Gynecol Scand Suppl. 1982;108:63-5
pubmed: 6751016
J Pediatr. 2015 Aug;167(2):238-45
pubmed: 25957977
J Pharm Health Care Sci. 2019 Apr 16;5:7
pubmed: 31019720